Zai Lab (ZLAB) Cost of Revenue (2020 - 2026)
Zai Lab's (ZLAB) quarterly Cost of Revenue came in at $38.3 million in Q1 2026, up 19548.72% year-on-year from N/an in Q1 2025, and down 79.83% quarter-over-quarter from $190.0 million in Q4 2025.
Zai Lab (ZLAB) Cost of Revenue (2020 - 2026) Analysis & Trends
Zai Lab has disclosed Cost of Revenue across 7 years of filings, most recently posting $38.3 million for Q1 2026.
- Cost of Revenue for Q1 2026 came in at $38.3 million, up 19548.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $228.6 million (up 25.37% YoY), and the FY2025 annual result was $190.5 million, up 29.5% from the prior year.
- Cost of Revenue came in at $38.3 million for Q1 2026 at Zai Lab, down from $190.0 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $190.0 million in Q4 2025 to a low of $119000.0 in Q3 2025.
- The 5-year median for Cost of Revenue is $21.1 million (2022), against an average of $41.2 million.
- Across the five-year window, Cost of Revenue slumped 99.42% in 2025 and surged 19548.72% in 2026, its largest moves.
- Zai Lab's Cost of Revenue stood at $20.9 million in 2022, then jumped by 357.92% to $95.8 million in 2023, then soared by 53.09% to $146.7 million in 2024, then climbed by 29.52% to $190.0 million in 2025, then sank by 79.83% to $38.3 million in 2026.
- The last three Cost of Revenue figures came in at $38.3 million (Q1 2026), $190.0 million (Q4 2025), and $119000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 2.05 Mn |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 38.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.32 Mn |
| Mar 31, 2026 | 38.32 Mn |
| Dec 31, 2025 | 189.99 Mn |
| Dec 31, 2025 | 189.99 Mn |
| Sep 30, 2025 | 119,000.00 |
| Sep 30, 2025 | 119,000.00 |
| Jun 30, 2025 | 217,000.00 |
| Jun 30, 2025 | 217,000.00 |
| Mar 31, 2025 | 195,000.00 |
| Mar 31, 2025 | 195,000.00 |
| Dec 31, 2024 | 146.69 Mn |
| Dec 31, 2024 | 146.69 Mn |
| Sep 30, 2024 | 348,000.00 |
| Sep 30, 2024 | 348,000.00 |
| Jun 30, 2024 | 35.15 Mn |
| Jun 30, 2024 | 35.15 Mn |
| Mar 31, 2024 | 33.62 Mn |
| Mar 31, 2024 | 33.62 Mn |
| Dec 31, 2023 | 95.82 Mn |
| Dec 31, 2023 | 95.82 Mn |